 |
||
About CNS Response
|
Links
|
|
The psychiatric treatment market accounts for 7.4% of healthcare spending, second only to heart disease. In the U.S., depression affects more than 18 million people; physicians write 11 million prescriptions per month to treat depression. Other frequently reported central nervous system (CNS) disorders include anxiety, addiction, eating disorders and schizophrenia. In most medical specialties, physicians base their diagnoses and treatment plans on the results of objective tests. But psychiatric disorders are diagnosed based on the patient’s behavior, or symptoms. Often, a patient is misdiagnosed or given a drug to which the patient is treatment resistant, or one that makes a situation worse. CNS medications are powerful with potentially dangerous side effects. This is problematic when prescriptions for these medications are determined by trial and error. When treating patients with treatment-resistant neurobehavioral disorders, the use of objective physiologic data can provide valuable information to the physician. Referenced-EEG is a tool to provide objective neurophysiology-based, patient-specific information to qualified medical professionals. The Referenced-EEG report contains information for the treating physician on what medications past patients with similar EEG patterns used to achieve positive outcomes.
|
|
|
